Axially directed blood plasma flow can significantly accelerate thrombolysis of non-occlusive blood clots. Viscous forces caused by shearing of blood play an essential role in this process, in addition to biochemical fibrinolytic reactions. An analytical mathematical model based on the hypothesis that clot dissolution dynamics is proportional to the power of the flowing blood plasma dissipated along the clot is presented. The model assumes cylindrical nonocclusive blood clots with the flow channel in the centre, in which the flow is assumed to be laminar and flow rate constant at all times during dissolution. Effects of sudden constriction on the flow and its impact on the dissolution rate are also considered. The model was verified experimentally by dynamic magnetic resonance (MR) microscopy of artificial blood clots dissolving in an in vitro circulation system, containing plasma with a magnetic resonance imaging contrast agent and recombinant tissue-type plasminogen activator (rt-PA). Sequences of dynamically acquired 3D low resolution MR images of entire clots and 2D high resolution MR images of clots in the axial cross-section were used to evaluate the dissolution model by fitting it to the experimental data. The experimental data fitted well to the model and confirmed our hypothesis.
Introduction
Restoring vessel patency by dissolving blood clots is the goal of thrombolytic therapy, which has rapidly expanded in the area of treating myocardial infarction during the last two decades of the past century (The ISIS-2 Investigators 1988, Gruppo Italiano per lo Studio della Sopravvivenza nell 'Infarto Miocardico 1990 , The GUSTO investigators 1993 and is now increasingly moving into the realm of treating acute ischaemic stroke (Clark et al 1999 , Hill and Buchan 2005 , Sekoranja et al 2006 . In addition, thrombolytic treatment is valuable in treating haemodynamically significant pulmonary embolism (Goldhaber et al 1993 , Konstantinides et al 2002 and acute/subacute arterial thrombosis (Ouriel et al 1998 (Ouriel et al , 2004 .
Biochemically, thrombolysis starts with the activation of the proenzyme plasminogen into the active serine protease plasmin (Collen 1999) . Several plasminogen activators such as a recombinant tissue-type plasminogen activator (rt-PA) or its modified variants reteplase or tenecteplase may be used in pharmacological doses to initiate thrombolysis (The GUSTO III Investigators 1997, Spohr et al 2005) . As an effective and safer alternative to using plasminogen activators, local infusion of plasmin into the clot has been successfully applied in experimental animals (Marder et al 2001) . The final outcome of thrombolysis depends on the properties of the thrombolytic agent, clot structure and the characteristics of molecular transport into the clot (Blinc and Francis 1996) . Occlusive clots are recanalized by slowly penetrating channels that follow the path of slowly permeating plasma which carries the thrombolytic agent. After the first reperfusion channel pierces the entire length of the clot, flow of plasma through the clot is accelerated, and thrombolysis proceeds at the surface of the flow channel in a perpendicular direction, eroding the remaining clot. However, the clot is rarely completely dissolved, and its remnants pose a risk of rethrombosis (Blinc and Francis 1996) .
The biophysical environment and its impact on thrombolytic processes in occlusive clots is fairly well described in the literature (Zidanšek et al 1995 , Zidanšek and Blinc 1991 , Diamond and Anand 1993 , Anand and Diamond 1996 , Anand et al 1997 . In addition, thrombolysis in low velocity axially directed blood flow has already been studied and mathematically modelled. Pleydell et al (2002) developed a mathematical model of post-canalization thrombolysis in low velocity flow that takes into account the changing concentrations of the major components of the fibrinolytic system. A similar model for thrombolysis of mural clots has been proposed by Wootton et al (2002) .
However, relatively little is known about the influence of high velocity axially directed blood flow on the thrombolysis of non-occlusive clots. The results of Sakharov and Rijken (2000) , as well as our own results (Tratar et al 2004) , show that high velocity plasma flow significantly enhances the dissolution of blood clots when favourable biochemical conditions are present. We have recently presented a model that takes into account the mechanical forces generated at the clot-plasma interface in addition to the biochemical conditions (Serša et al 2005) . Our main assumption was that viscous mechanical forces act in parallel with the fibrinolytic system, which means that increasing the axially directed plasma velocity enhances the efficiency of clot erosion at its surface (Serša et al 2005) .
This paper refines our initial model by taking into account the effects of sudden blood vessel constriction at the site of the non-occlusive thrombosis and evaluates its impact on the rate of clot dissolution. The model was verified experimentally by dynamic magnetic resonance microscopy of non-occlusive blood clots dissolving in an artificial circulation system.
Theory
The proposed model for blood flow through a blood vessel that is partially occluded by a blood clot is based on the following assumptions. Firstly, the flow through the normal vessel, as well as through the channel along the clot, is laminar at all times. Secondly, the blood clot has a flow channel in the centre that expands radially from the centre as the clot dissolves. Thirdly, the flow rate φ V through the clot is constant throughout the dissolution process. In addition, the model accounts for the entrance phenomena of laminar flow entering a stenotic region. . Flowing blood that enters the flow channel along the centre of the clot has initially a flat velocity profile. The profile is progressively modified downstream to a parabolic velocity profile due to viscous forces caused by shearing of blood. Blood adjacent to the wall is retarded, while blood in the core is accelerated to maintain the flow rate constant. Downstream of the distance from the entrance known as the entrance length (z 0 ) a fully developed flow is established. The thickness of the layer with viscous dominating forces (dark grey) increases downstream and covers the whole clot cross-sectional area at distances larger than the entrance length.
Blood velocity model
According to Poiseuille's law, a normal non-occluded vessel with laminar flow has a parabolic velocity profile (Dryden et al 1956) . The profile changes as blood enters the flow channel of the clot. The channel has a smaller cross-sectional area than the normal vessel and blood flow accelerates after entering the flow channel to maintain the constancy of flow rate. At the entry point the velocity profile is flat so the shear velocity is very high at the wall and slip conditions apply. As blood moves downstream, the blood flow velocity adjacent to the wall is progressively retarded due to shear forces exerted by the vessel wall on the blood, while blood in the core region is accelerated to maintain the same flow rate. Ultimately, further downstream, at a distance from the entrance point known as the entrance length (Nichols and O'Rourke 2005) , a parabolic velocity profile is established. With an increasing distance from the entrance, a layer with dominating viscous effects (a boundary layer) progressively expands from the wall, covering more and more of the cross-sectional area of the flow channel. At distances from the entrance larger than the entrance length, the boundary layer covers the whole cross-sectional area of the flow channel and the flow profile is then fully developed (figure 1). The thickness of the boundary layer and the entrance length can be estimated by observing the dynamics of a small volume of blood within the boundary layer. Suppose the volume element spans two parallel surfaces with area S at radial distances r 1 and r 2 from the axis of the flow channel (figure 1). The net viscous force on the element is equal to the difference between the shear velocities ∂v/∂r at the two surfaces multiplied by the surface area S and the viscosity η:
The second derivative ∂ 2 v/∂r 2 in equation (2.1) can be approximated by the average blood velocity in the flow channel v 0 = φ V /(π R 2 ) divided by the boundary layer thickness squared, δ 2 . If the external forces on the volume element are not balanced, the volume element is accelerated according to Newton's law
Here, ρ is the blood density and S(r 2 − r 1 ) is the volume of the element. The element acceleration a in equation (2.2) is approximated by the average velocity v 0 divided by the acceleration time which is equal to the entrance distance z between the entrance and the boundary layer divided by v 0 . From equations (2.1) and (2.2), it follows that the boundary layer thickness δ increases with the square root of the distance from the entrance point z:
The boundary layer extends over the whole channel cross-section (δ = R) at entrance distances z equal to the entrance length z 0 or larger. According to equations (2.1) and (2.2), the entrance length z 0 is proportional to the channel diameter d = 2R and the Reynolds number (Re = ρdv 0 /η):
The proportionality constant of 0.06 for the entrance length in equation (2.4) was determined experimentally for a round tube (Nichols and O'Rourke 2005) . Knowing the boundary layer axial profile (equation (2.3)) enables the construction of a simple model for the velocity profile in the entrance region. The model assumes a flat velocity profile in the core region that continuously converts into a parabolic velocity profile within the boundary layer, ending with zero velocity next to the channel walls. In both regions, the flow velocity is assumed to have an axial direction. Additionally, the conservation of the flow rate has to be taken into account as well. Combining all of the above assumptions and conditions with equation (2.3) for the boundary layer axial profile yields the following velocity profile as a function of the radial distance r and the entrance distance z:
(2.5)
Rate of clot dissolution
After a pharmacological concentration of a thrombolytic agent is added to the blood that flows in our idealized vessel partially occluded by the non-occlusive clot, the clot begins to dissolve and the channel along the clot expands radially as thin layers of the clot are gradually removed by the flowing blood. Now we come to the essence of our proposed model, namely that for every biochemical setting, the rate of clot dissolution is proportional to the dissipated power of the blood flowing along the clot. In other words, the higher are the physical forces on the clot surface, the fewer the plasmin-susceptible bonds in the fibrin network that have to be cleaved biochemically to remove a corresponding fragment of the non-occlusive clot. The work dW done by the flowing blood on the surface of the clot in the flow channel is equal to the viscous force F of the flowing blood multiplied by the distance ds the blood in contact with the clot travelled. The viscous force is equal to the surface area S of the flow channel in contact with the flowing blood multiplied by the blood viscosity η and by the shear velocity ∂v/∂r of the flowing blood in contact with the clot, while the characteristic distance is equal to the characteristic depth λ to which the forces have an effect, multiplied by the shear velocity and the time interval dt in which the work is done:
The shear velocity of the flowing blood in contact with the clot, i.e. at r = R, can be calculated from the velocity profile given by equation (2.5):
In our model, we assume that the work dW of the flowing blood in contact with the clot was used entirely for the removal of a thin layer of thickness dR from the surface of the clot flow channel and that the work is proportional to the volume dV of the layer removed:
Here, c is a proportionality constant incorporating the efficiency of the thrombolytic agent and other factors of the biochemical setting. The more efficient the thrombolytic agent, the lower the constant c and the lower the work dW needed for the removal of a clot layer. In fact the constant c is not exactly a constant, even within the same experiment. The reason for that lies in the biochemical properties of every thrombolytic agent. After injection of the thrombolytic agent into the circulation system, a certain time is needed for the agent to reach the clot, migrate into it and start converting plasminogen into activated plasmin. In the model, we assume that the time dependence of the thrombolytic agent activity (reciprocal constant c) can be described by a Fermi-like function
which is controlled by two parameters: τ , the average time the agent needs to activate the plasmin, and , the transition time between the inactive and fully active states of the fibrinolytic system, while 1/c ∞ is the final activity of the fibrinolytic system. Two different expressions for the work, (2.6) and (2.8), may be equated, where the proportionality constant c can be replaced by expression (2.9) and the shear velocity by expression (2.7) which yields the following differential equation:
Before equation (2.10) is integrated, the average flow velocity v 0 may be replaced by
and the boundary layer thickness δ by expression (2.3). Thus, two differential equations describing the clot dissolution rate are obtained, one for entrance distances lower than the entrance length and the other for entrance distances larger than the entrance length. The fact that the entrance length z 0 is constant through the whole dissolution process (z 0 is proportional to the flow rate which is constant, equation (2.4)) makes the integration of the two differential equations easy:
, z z 0 .
(2.11)
Here, R 0 is the initial radius of the flow channel at the beginning of dissolution and T 7 is a time constant equal to
Finally, after integration of equation (2.11) the following equation for the clot dissolution rate may be obtained:
(2.13) R ∞ in equation (2.13) corresponds to the radius of the normal blood vessel, i.e. the maximum flow channel radius when the whole clot dissolves. The dissolution time t D , defined by the condition R(z, t D ) = R ∞ , is different for different entrance distances z. As follows from equation (2.13), the dissolution time is equal to
(2.14)
The relatively complex expression in equation (2.14) simplifies to t D τ + T 7 when the entrance distance is larger than the entrance length, the initial flow channel is narrow and T 7 and τ are much smaller than . For convenience, we introduce a parameter reflecting the occlusion level. The occlusion level is defined as the ratio of the cross-sectional area of the clot to the cross-sectional area of the normal non-occluded vessel:
The Reynolds number
In order to know whether the assumption in the model that the blood flow is laminar at all times is justified or not, one has to know under what conditions flow turns from the laminar to the turbulent regime. This may be determined by a criterion based on the Reynolds number (Dryden et al 1956) :
It was found experimentally that for normal smooth surfaces flow is most likely turbulent when Re is more than 3000 and laminar when it is less than 2000 (Colebrook 1938 ). The transition between laminar and turbulent flow is usually not very sharp, and there may be some intermediate phenomena (typically when 2000 < Re < 3000). Flow in this regime is usually still laminar close to the walls of the vessel and turbulent in the centre. For Re higher than 3000, flow becomes fully turbulent. The first turbulences in flow do not always occur at exactly Re = 2000. This is just an approximate value. A laminar flow regime may also persist at Re much higher than 2000 when the vessel walls are very smooth and may also turn into fully developed turbulent flow at Re much lower than 3000 if the walls are rough (Schiller 1922) .
Materials and methods

Artificial blood clots
Blood was collected from the cubital vein of a healthy male volunteer into tubes (Vacutainer, Becton-Dickinson, Germany) containing 1 volume part of 0.129 mol l −1 Na citrate for 9 volume parts of blood. Clotting was induced in vitro by adding calcium (50 µl CaCl 2 at 2 mol l −1 per ml of blood) and thrombin (Thrombin, Sigma, Germany) at a final concentration of 1 NIH unit ml −1 of blood. Clot retraction was inhibited by the phosphodiesterase inhibitor UDCG 212 (Boehringer, Germany) at a final concentration of 20 µmol l −1 (Šabovič et al 1990) that was added to the citrated blood before mixing it with thrombin. Non-retracted clots were formed in cylindrical glass tubes with an inner diameter of 3 mm and a length of 3 cm. The inner surface of the glass tubes was mechanically etched and covered by a layer of purified fibrin in order to assure good adherence of the clots (Carr et al 1977) . The clot transition at the leading and the trailing edge was quite abrupt. After at least an hour at room temperature to allow for fibrin formation, the clots were pierced lengthways on the outside at the wall surface by a needle with a diameter of 0.7 mm to create a flow channel along the clot. Clots were pierced on the outside because in this way clot adhesion to the glass wall was less likely to be compromised than if they were pierced through the centre as assumed in the model. The occlusion level was then initially equal to x = 0.946, and it progressively decreased towards 0 during dissolution. The glass tube with clot was connected by a flexible hose to a pump that generated a constant pressure of either 15 000 Pa or 3000 Pa, which represent the mean arterial and venous pressures in man. The hose connecting the pump and the clot was 1.7 m long (3.4 m to the clot and back) and also had an inner diameter of 3 mm. In each experiment, the artificial circulation system was filled with approximately 0.5 l of blood plasma at room temperature, which was usually about 20
• C. According to the literature (Nichols and O'Rourke 2005) , the viscosity of blood plasma is 1.8 times higher than the viscosity of water, which yields an estimated value for plasma viscosity at a room temperature of 0.018 poise, whereas the density of plasma is about 3.5% higher than the density of water, i.e. 1035 kg m −3 .
Flow regimes
Two blood flow regimes were tested. In the high velocity regime, corresponding to shear forces generated in the arterial system at the site of a significant stenosis, the stronger pump was directly connected to the hose leading to the clot. In the low velocity regime, corresponding to average shear forces in the venous system, the weaker pump was connected to the hose via a needle with a narrow opening that served as a serial resistor to additionally reduce the flow. For both regimes, volume flow rates were measured in the circulation system with a clot before adding the thrombolytic agent (x = 0.946). The volume flow rate was measured by temporally redirecting the outlet hose from the container with the pump to an empty container of a known volume and measuring the time needed to fill the container with plasma. From these (table 1) . During clot dissolution some of the flow parameters changed as the channel radius expanded. Assuming the flow rate was constant, the average velocity was inversely proportional to the channel radius squared, and the Reynolds number was inversely proportional to the channel radius while the entrance length remained constant. Flow rate measurements made at the beginning of dissolution (x = 0.946) and after complete clot dissolution (x = 0, the glass tube with the remaining clot was replaced with an empty glass tube) showed that the flow rate was fairly constant throughout the dissolution process in the low velocity regime, while it moderately increased towards the end of dissolution in the high velocity regime due to the pump generating a constant pressure.
Dynamic magnetic resonance imaging
The artificial circulation system was positioned in the magnet of a magnetic resonance imaging (MRI) scanner that consisted of a 100 MHz (proton frequency) horizontal bore Oxford superconducting magnet (Oxford Instruments, Oxon, UK), a TecMag NMR console (TecMag, Huston, TX, USA) and a Bruker micro-imaging gradient system (Bruker, Ettlingen, Germany) with maximum gradients of 300 mT m −1 . Initially, the glass tube with the clot was inserted into a 25 mm diameter radio-frequency probe in the centre of the magnet, while the pump immersed in the plasma container was located outside the magnet where the magnetic field was low enough to allow normal pump operation. Then, the circulation system was tested for stability, ensuring that the system contained no air bubbles which could obstruct plasma flow. After that dynamic MR imaging was started. For the first 10 min, clots were imaged without the thrombolytic agent in the circulation system to assure that clot dissolution was not caused by mechanical erosion alone; then the thrombolytic agent recombinant tissue activator of plasminogen rt-PA (Actylise, Boehringer, Germany) was added at a pharmacological dose of 2 µg ml −1 to the plasma, as well as the MR imaging contrast agent Gd-DTPA (Magnevist, Berlex Lab., Germany) at 1 mmol l −1 and dynamic imaging continued for another 40 min. In control experiments, clots were dynamically imaged without the thrombolytic agent and the MRI contrast agent for the entire period of 40 min.
To evaluate the effect of transition phenomena associated with the significantly larger shear velocity of blood at the entrance point which progressively decreases towards the entrance length, some clots were imaged dynamically by the low resolution rapid 3D RARE MR imaging technique (Haacke et al 1999) . The clots were imaged just in fast flow as in slow flow the theoretically expected entrance length was too small to produce results detectable by 3D imaging. The image matrix consisted of 32 by 32 by 128 points and the field of view 6.2 by 6.2 by 25 mm 3 , yielding an isotropic image resolution of 20 µm. The inter-echo time and repetition rate were 3.3 ms and 3 s, respectively, while the image signal was acquired using sequential k-space encoding with the RARE factor of 32 (one k-space plane was acquired after each excitation) so the total scan time was 1 min 44 s. 3D images were reconstructed with TecMag's NTNMR software and further processed by the volume rendering subroutine of the Image-J program (Java version of the NIH-Image program, NIH, USA). Channel radius profiles R(z) were calculated from measured occlusion levels x(z) using the relation in equation (2.15), i.e. R(z) = R ∞ √ 1 − x(z). Most blood clots were imaged dynamically by the high resolution conventional spin-echo MRI technique in a transversal slice positioned centrally to the clot, 15 mm downstream from the entrance point. The images were T 1 weighted with echo time and repetition rate parameters TE/TR = 8/400 ms, the scan time was 1 min 50 s, the imaging field of view 2 cm, the imaging matrix 256 by 256 points and the slice thickness was equal to 2 mm. Clot dissolution was monitored for 40 min so that a time sequence of 20 images in the identical slice position and orientation was acquired in each dissolution experiment. All images were later analysed by the Image-J program. The cross-sectional area of the remaining clot was measured as a function of time to obtain the occlusion level time dependence in the clot centre for each clot in the study. These results were then divided into two groups depending on the velocity regime (fast or slow). In each group, there were at least four clots.
Data fitting and modelling
The experimental data were analysed by the appropriate mathematical model given by equations (2.13)-(2.15). The model parameters T 7 , τ and were extracted by finding the best fit of the model to the experimental occlusion level data. Fitting was done by the Origin computer program (Origin Lab, Northampton, MA, USA) which uses the LevenbergMarquardt method for fitting functions with nonlinear parameters (Press et al 1989) . Plots of the model function were created by the Mathematica computer program (Wolfram Research, Champaign, IL, USA).
Results
Clot dissolution can best be seen in the dynamically acquired 3D images. Figure 2 shows a typical clot at the beginning and at the end of a high velocity dissolution experiment. In the beginning, the channel is narrow and evenly wide all along the entire clot. By the end (after 36 min), a substantial portion of the clot has been dissolved and removed by the flowing plasma. As expected, dissolution was faster at the entrance and there the channel became wider than downstream where dissolution was not as fast. However, the entrance effect was not as great as could be expected from the entrance length. This is because the plasma shear velocity at the wall (equation (2.7)) and the related dissolution rate (equation (2.6)) decrease quite abruptly with an increasing entrance distance. The entrance length in this experiment was equal to 70 mm (table 1), which is more than twice the length of the clot, but a noticeable difference in the rate of clot dissolution was limited to just the first few millimetres downstream from the entrance. Further downstream, the channel axial profiles were very much alike. In figure 2, due to RF coil restrictions, an image artefact, seen as a signal void, was produced at the distal edge of the clot.
The results of 3D MRI, where noticeably faster dissolution was noted only at entrance distances up to 7 mm in comparison to the rest of the clot, support our decision to dynamically image most of the clots only in 2D in one axially oriented slice through the centre of the clot. Three control clots were exposed to the rapid flow of plasma without the thrombolytic agent, and after 20 min showed only a 5.3 ± 1.5% decrease of the occlusion level. On the other hand, when rt-PA was present, clot dissolution was much more pronounced. An example of dynamic MR microscopy of clot dissolution in the high and in the low velocity regimes (table 1) is shown in figure 3 . The difference between the dissolution rates is apparent. Also, the difference in progression of the MRI contrast agent (Gd-DTPA, mol. wt = 590 Da) into the clot is significant. Penetration of the Gd-DTPA-labelled plasma was used as a surrogate for the penetration of the thrombolytic agent (rt-PA, mol. wt = 68 kDa) into the clot. After 6 min of flow, Gd-DTPA-permeated areas extended 2.0 ± 0.4 mm from the border of the flow channel into the clot with fast flow, but only 0.4 ± 0.13 mm with slow flow. Figure 4 shows the time dependence of the occlusion level, i.e. the dissolution curve, in the high and in the low velocity regimes, which was obtained by an analysis of dynamic MR image sequences as described earlier. In both velocity regimes, the dissolution model fitted the experimental MRI data well. Model parameters that yielded the best fit are shown in table 2.
The difference in the dissolution rate between the high and the low velocity regimes is apparent. The difference is mainly due to different blood flow velocities in the channel, resulting in a different supply with the thrombolytic agent and different mechanical work of the flowing blood applied to the superficial layer of the clot in the channel. The dissolution rate difference is also reflected in a more than 250-fold increase in the parameter T 7 and therefore a 250 times slower dissolution in the low velocity regime in comparison to the high velocity regime. The experimentally obtained ratio between the parameter T 7 in the low and in the high velocity regimes agreed quite well with the theoretically obtained ratio. Assuming that the activity of the thrombolytic agent c and the characteristic depth λ are flow velocity independent, the theoretical ratio between the parameter T 7 in the low and in the high velocity regimes according to equation (2.12) is equal to the square of the ratio between the flow rate in the high and in the low velocity regimes, i.e. T
. Taking the flow rates from table 1, this ratio is equal to 490, which is reasonably close to the experimentally obtained value of 250. The model parameter τ , corresponding to the delay from the injection of the thrombolytic agent to the point when the initial clot dissolution was observed, is equal to 8 min (477 s) in the high velocity regime and is approximately two and a half times longer in the low velocity regime. This relatively large difference is due to the considerably slower flow rate in the low velocity regime than in the high velocity regime and the associated long travel time of the thrombolytic agent from the container to the clot.
Once the parameters of the dissolution model in equation (2.13) are determined, the time dependence of the occlusion level can be calculated for any entrance distance z, and the axial profile of the flow channel can be calculated for any time t after the beginning of visible dissolution. Figure 5 depicts plots of these two dependences using model parameters of the high velocity regime from table 2. From the plots, it can be clearly seen that dissolution is considerably faster at the entrance of the flow channel than further downstream. The difference is apparent within the first 5 mm, which is considerably less than the calculated entrance length of 70 mm. For distances larger than 5 mm, no significant difference in the dissolution rate is expected, i.e. occlusion level time dependences and channel radii are practically identical. This is in agreement with the results of 3D MR imaging experiments (figure 2) where significant differences in the dissolution rate were observed only within the first few millimetres of the channel downstream from the entrance.
Discussion
The model presented for the dissolution of non-occlusive blood clots is based on the hypothesis that, in addition to fibrinolytic biochemical processes, viscous forces of axially flowing blood along the clot play an essential role in clot degradation. With increasing velocity of axial blood flow, the mechanical contribution to clot dissolution increases and vice versa; with decreasing velocity of axially flowing blood, thrombolysis approaches a purely biochemical process in a no-flow environment.
We developed a relatively simple mathematical model for the dissolution of non-occlusive blood clots for varying biochemical and biophysical circumstances. The model, given by equation (2.13), has just three parameters that control dissolution dynamics: T 7 , τ and , and two additional geometrical parameters: R ∞ and z 0 . The dissolution parameter T 7 (equation (2.12)) incorporates the relevant biophysical properties of blood plasma, as well as an approximation of the biochemical properties of the fibrinolytic system in the form of the 'biochemical proportionality constant' c. The time delay parameter τ corresponds to the time lag between the injection of the thrombolytic agent into the blood and the time when the surface layer of the clot is sufficiently biochemically degraded for the flowing blood to remove it mechanically, while the parameter controls the rate at which the fibrinolytic system is activated. The geometrical parameter R ∞ is equal to the radius of vessel after complete clot dissolution and z 0 is the entrance length (equation (2.4)), a parameter that mainly reflects the biophysical properties of the dissolution system, namely flow rate, viscosity and density of the blood plasma. The geometrical parameters can be measured or calculated from other known parameters of the model. The real unknowns are the dissolution parameters. In most cases, these cannot be directly calculated but can be extracted by fitting the model to the experimentally obtained time dependences of the occlusion level.
The proposed model was applied to explain our experimental data in 2D and yielded a reasonably accurate fit. Dissolution dynamics in 3D experiment in figure 3 , that was performed substantially later than 2D experiments, was somewhat slower due to less efficient rt-PA; however, measured dissolution channel radius profiles well agree with the model profiles in figure 5(b) . From the graphs of clot dissolution in figure 4, it can be seen that clot dissolution was far more efficient in fast flow than in slow flow. At least two processes significantly contribute to faster thrombolysis in fast blood flow. The first is the supply of the thrombolytic agent, which is far more efficient in fast flow than in slow flow, and the second is that forces exerted by the flowing blood at the surface layer of the clot in the flow channel increase with flow velocity. Assuming that the origin of the forces is blood viscosity, the forces are linearly dependent on blood velocity. The processes to some extent compete with one another. That is, at higher blood velocities when clot dissolution is faster, a much shorter time is available for the fibrinolytic system to degrade a volume element of the clot before it is removed by the flowing blood. This effect is not included in our model and is hidden in the biochemical constant c (in relation to equation (2.8)). The constant c in our model is assumed to be independent of the blood flow velocity which is not entirely true. The effect was also manifested in our experiment as the difference between the theoretical and the experimental ratios of T L 7 T H 7 in the low and in the high velocity regimes. The theoretical ratio of the parameters is equal to 490 while the experimental ratio of 250 was half of that. This means that in our experiment the biochemical constant c increased twofold between the slow and fast flow regimes, i.e. twice as much mechanical work was needed to remove a volume element of the clot in fast flow than in slow flow. Overall, clot dissolution in fast flow was still much more efficient than in slow flow because the increase of work needed to remove the volume element is more than compensated by the large increase of mechanical forces of the flowing blood to the clot.
From the known blood plasma velocity in the connecting hose, which was equal to 0.23 m s −1 in the high velocity regime, and the length of the hose from the injection site to the clot, which was equal to 1.7 m, we know that the initial front of the thrombolytic agent reached the clot no later than 7.4 s after being injected into the blood plasma container surrounding the immersed pump. The transport time of the thrombolytic agent to the border of the clot was thus much shorter than the measured parameter τ , which corresponds to the time delay between the injection and the initiation of dissolution, which in this experiment was equal to 8 min. The bulk of the delay was therefore needed for the thrombolytic agents to penetrate into the superficial clot layer and to induce sufficient biochemical degradation so that the lining layer could no longer resist the forces of the axially flowing blood. Penetration of the Gd-DTPA-labelled plasma into the clot, which was measured by MRI as a surrogate for the penetration of the thrombolytic agent, was much more efficient in fast flow than in slow flow, which is another reason for better clot dissolution with higher axial velocities of blood plasma flow.
Although our model gives a useful insight, it has several limitations. Describing the biochemical setting by a single constant c is of course an oversimplification, since the concentration of reactants may change over time. A classical example of this is the gradual depletion of plasminogen from circulating blood during the use of non-fibrin-specific plasminogen activators, so that fibrinolysis becomes progressively less efficient with time (Torr et al 1992) . Our model is also somewhat inaccurate in describing flow in the channel. The model assumes that the flow channel is positioned centrally to the clot, while in the experiments performed the channel was made on the outside of the clot. Additionally, in the later stages of the dissolution, the channel was no longer uniform, as assumed in the model. It was wider at the entrance than further downstream. Since the flow equation (2.5) is derived for a uniform channel and does not take into account the changing channel profile during dissolution, the shear rates and the associated dissolution rates may be different at the entrance than predicted by the model. Addition of a channel profile correction to the model would further complicate the model and make it analytically unsolvable. A more exact calculation of the flow distribution along the channel may be obtained by solving the Navier-Stokes equation (Faber 1995) of flow for this particular geometry. This solution could then be used to calculate the new shear velocities at the channel wall, and from these the new position-dependent dissolution rate would be calculated according to equations (2.6) and (2.8), yielding a new channel profile, then again a new flow distribution and so on. By iteratively repeating this computational cycle, a numerical solution for the channel radius as a function of the entrance distance z and time t could be obtained. Such a numerical solution would be more accurate, but much less informative than the analytical solution given by equation (2.13). It would also be interesting to verify the calculated flow distributions with MRI measurements of the velocity map of flowing blood through the clot (Haacke et al 1999) . The model assumes the flow rate to be constant at all times of dissolution. However, this was not entirely true in the experiment, especially not in the high velocity rate experiment. The pump that was used in the experiment generated a constant pressure difference of 15 kPa and not a constant flow. Therefore, the flow rate was lower at the beginning of the experiment, when most of the pressure dropped across the clot, than later when the pressure drop was evenly distributed along the whole circulation system. This effect to some extent is also reflected in the high velocity regime dissolution plot ( figure 4(a) ), which has a discrepancy between the experimental data and the model curve at times larger than 1000 s.
Some other physiologically relevant phenomena have also not been accounted for in detail. All clots were prepared from blood of one subject which may limit the generalizability of our results. We used non-retracted whole blood clots that are more susceptible to thrombolysis than fully retracted clots or platelet-rich thrombi (Šabovič et al 1989 (Šabovič et al , Blinc et al 1992 . However, we have previously reported on similar effects of rapid flow versus slow flow of plasma in fully retracted blood clots (Tratar et al 2004) . Further, the flow in arteries is pulsatile (we used a steady flow) and the circulating blood has a temperature of about 36
• C (we used blood plasma at a room temperature of 20
• C). Pulsatile flow may promote the dissolution rate as it helps in creating eddies that improve the delivery of the thrombolytic agent to the clot and also have an increasing effect on the shear velocity of the streaming blood at the channel wall. Furthermore, thrombolysis with the tissue plasminogen activator (rt-PA) is temperature-dependent. Yenari et al (1995) found lower plasminogen activation and fibrinogen degradation at 25
• C compared to 37
• C, but negligible differences at 10 • C, 0
• C and −8 • C. A temperature increase of plasma from 20
• C to 37
• C would increase the efficiency of the thrombolytic agent by a factor of approximately 1.8, assuming the catalytic efficiency for each temperature increase of 10
• C to be that reported in the literature (Blinc et al 1993 , Kavanau 1950 , so that the biochemical relevant constant c would decrease by a factor of 1.8 and the same would also happen to the parameter T 7 . A temperature increase would also result in a decrease of the delay parameter τ , as well as the transition width parameter . No significant change of the channel profile spatial dependence is expected with a rise in temperature. The model assumes that the flow is laminar throughout dissolution. As the Reynolds number at the beginning of dissolution in the high velocity regime of 1660 is quite close to 2000, which is considered to be the transition from the laminar to the turbulent regime, and the surface of the clot is rough and the flow in real arteries is pulsatile, it is quite possible that at least in the small region of the channel the flow reverts to the turbulent regime. In the case of turbulent flow, equation (2.5) for the flow velocity in the uniform channel no longer holds nor does equation (2.6) for the work of the streaming plasma on the clot. Turbulent flow in a round tube does not have a parabolic velocity profile, but rather a flat profile in the core region and a laminar-like profile at the wall. In turbulent flow kinematic forces, which have their origin in the change of momentum, dominate over viscous forces. As kinematic forces increase with the velocity squared, the dissipated power of the streaming plasma as well as the dissolution rate, is proportional to the cube of the average velocity and not to the velocity squared, as in the case of laminar flow. Faster dissolution is therefore expected with turbulent flow than with laminar flow.
Conclusion
Flow plays an essential role in the dissolution of non-occlusive blood clots. Convective flow increases the supply of the thrombolytic agent to the clot, while axially oriented flow exerts mechanical forces on the surface of the clot in the flow channel and thus promotes the removal of biochemically degraded parts of the clot from the flow channel. In fast flow, the increase of the dissolution rate is too great to be explained only by better permeation of the thrombolytic agent into the clot and more efficient biochemical degradation. The effect can be mainly attributed to the work of mechanical forces of streaming blood on the clot. We developed an analytical mathematical model that explains the effect of fast axial blood flow on the dissolution of non-occlusive blood clots. First, an approximation of the flow velocity profile in a uniform round tube after a sudden constriction was derived. Then, assuming the flow to be laminar, the dissolution rate, which was proportional to the square of the blood shear velocity at the wall of the flow channel, was integrated and the flow channel profile during dissolution was obtained as a function of the entrance distance and the time after the beginning of visible dissolution. The model was verified by experimental MRI data for the time dependence of the occlusion level, and reasonably accurate fits of the model with the MRI data were obtained. As the presented model is completely analytical, it enables an easy understanding of the effects of various flow parameters or biochemical parameters on the progression of clot dissolution. The model should be further improved by incorporating the dynamics of fibrinolytic reactions and some additional physiological phenomena such as the effect of pulsatile flow and the possible occurrence of turbulence.
